Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination

doi:10.1007/s11684-021-0895-9

Front. Med.

2021, Vol. 15

Issue (6) : 938-941 https://doi.org/10.1007/s11684-021-0895-9

COMMENT

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination

Prathit A. Kulkarni^1,²(

), Vinay Prasad³

¹. Infectious Diseases Section, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
². Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
³. Department of Epidemiology and Biostatistics, School of Medicine, University of California-San Francisco, San Francisco, CA 94143, USA

Download: PDF(72 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Corresponding Author(s): Prathit A. Kulkarni

Just Accepted Date: 09 September 2021 Online First Date: 30 September 2021 Issue Date: 27 December 2021

Cite this article:

Prathit A. Kulkarni,Vinay Prasad. Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination[J]. Front. Med., 2021, 15(6): 938-941.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-021-0895-9
https://academic.hep.com.cn/fmd/EN/Y2021/V15/I6/938

1	U.S. Centers for Disease Control & Prevention. Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine. Press release on April 13, 2021. 2021. (accessed April 24, 2021)
2	U.S. Centers for Disease Control & Prevention. Health Alert Network Advisory on April 13, 2021. 2021. (accessed April 24, 2021)
3	U.S. Centers for Disease Control & Prevention. ACIP presentation slides: May 12, 2021 meeting. 2021. (accessed August 2, 2021)
4	G Saposnik, F Barinagarrementeria, RD Brown Jr, CD Bushnell, B Cucchiara, M Cushman, G deVeber, JM Ferro, FY Tsai. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42(4): 1158–1192 https://doi.org/10.1161/STR.0b013e31820a8364 pmid: 21293023
5	M Sánchez van Kammen, MR Heldner, J Brodard, A Scutelnic, S Silvis, V Schroeder, JA Kremer Hovinga, S Middeldorp, M Levi, S Hiltunen, E Lindgren, M Mansour, A Arauz, MA Barboza, SM Zuurbier, D Aguiar de Sousa, JM Ferro, U Fischer, TS Field, K Jood, T Tatlisumak, J Putaala, M Arnold, JM Coutinho. Frequency of thrombocytopenia and platelet factor 4/heparin antibodies in patients with cerebral venous sinus thrombosis prior to the COVID-19 pandemic. JAMA 2021; 326(4): 332–338 https://doi.org/10.1001/jama.2021.9889 pmid: 34213527
6	U.S. Centers for Disease Control & Prevention. ACIP presentation slides: April 23, 2021 meeting. 2021. (accessed April 24, 2021)
7	I See, JR Su, A Lale, EJ Woo, AY Guh, TT Shimabukuro, MB Streiff, AK Rao, AP Wheeler, SF Beavers, AP Durbin, K Edwards, E Miller, TA Harrington, A Mba-Jonas, N Nair, DT Nguyen, KR Talaat, VC Urrutia, SC Walker, CB Creech, TA Clark, F DeStefano, KR Broder. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA 2021; 325(24): 2448–2456 https://doi.org/10.1001/jama.2021.7517 pmid: 33929487
8	A Greinacher, T Thiele, TE Warkentin, K Weisser, PA Kyrle, S Eichinger. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021; 384(22): 2092–2101 https://doi.org/10.1056/NEJMoa2104840 pmid: 33835769
9	NH Schultz, IH Sárvoll, AE Michelsen, LA Munthe, F Lund-Johansen, MT Ahlen, M Wiedmann, AH Aamodt, TH Skattør, GE Tjønnfjord, PA Holme. Thrombosis and thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021; 384(22): 2124–2130 https://doi.org/10.1056/NEJMoa2104882 pmid: 33835768
10	M Scully, D Singh, R Lown, A Poles, T Solomon, M Levi, D Goldblatt, P Kotoucek, W Thomas, W Lester. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19. N Engl J Med 2021; 384(23): 2202–2211 https://doi.org/10.1056/NEJMoa2105385 pmid: 33861525
11	C Vayne, J Rollin, Y Gruel, C Pouplard, H Galinat, O Huet, V Mémier, T Geeraerts, R Marlu, G Pernod, G Mourey, A Fournel, C Cordonnier, S Susen. PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia. N Engl J Med 2021; 385(4): 376–378 https://doi.org/10.1056/NEJMc2106383 pmid: 34010527
12	U.S. Centers for Disease Control & Prevention. ACIP presentation slides: July 22, 2021 meeting. 2021. (accessed August 2, 2021)
13	United Kingdom Joint Committee on Vaccination and Immunisation. Use of the AstraZeneca COVID-19 (AZD1222) vaccine: Updated JCVI statement, 7 May 2021. 2021. (accessed August 2, 2021)
14	U.S. Centers for Disease Control & Prevention. ACIP presentation slides: July 22, 2021 meeting. 2021. (accessed August 2, 2021)

Viewed

Full text

Abstract

Cited

Shared

Discussed